MSH-2IA

N/A

Report date: 2024/11/27 16:48:08

Base Information

Drug NameMSH-2IA
Drug Alias NameMagSense® HER2 Imaging Agent(Imagion Biosystems)MagSenseMSH2IAMSH-2IA
ClassificationDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImagion Biosystems Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImagion Biosystems Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A